Shanghai ZJ Bio-Tech Co., Ltd (SHA:688317)

China flag China · Delayed Price · Currency is CNY
20.43
+0.53 (2.66%)
Mar 10, 2026, 11:29 AM CST
Market Cap3.53B +12.8%
Revenue (ttm)124.91M -30.1%
Net Income-34.30M
EPS-0.19
Shares Out177.52M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,314,690
Average Volume2,820,802
Open19.93
Previous Close19.90
Day's Range19.93 - 20.45
52-Week Range14.88 - 29.49
Beta0.54
RSI38.15
Earnings DateApr 24, 2026

About Shanghai ZJ Bio-Tech

Shanghai ZJ Bio-Tech Co., Ltd. engages in the research and development, production, and sale of molecular diagnostic reagents and instruments in China and internationally. It offers nucleic acid and real-time PCR kits, as well as consumables. The company was founded in 2005 and is based in Shanghai, China. [Read more]

Sector Healthcare
Founded 2005
Employees 275
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688317
Full Company Profile

Financial Performance

In 2025, Shanghai ZJ Bio-Tech's revenue was 124.91 million, a decrease of -30.08% compared to the previous year's 178.65 million. Losses were -34.30 million, -73.09% less than in 2024.

Financial Statements